This page shows the latest monoclonal antibody drugs news and features for those working in and with pharma, biotech and healthcare.
Novartis has set aside $100m to expand a production facility for monoclonal antibody (Mab) drugs in France, planning to boost capacity by 70%. ... inflammatory and anti-rejection drugs, as well as antibodies in late-stage clinical development.